zealand_logo_RGB_01.png
Zealand Pharma major shareholder announcement: Polar Capital
May 29, 2024 07:32 ET | Zealand Pharma
Company announcement – No. 28 / 2024 Zealand Pharma major shareholder announcement: Polar Capital Copenhagen, Denmark, 29 May 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50...
zealand_logo_RGB_01.png
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide
May 23, 2024 14:45 ET | Zealand Pharma
Company announcement – No. 27 / 2024 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide Mean...
zealand_logo_RGB_01.png
Zealand Pharma Announces Financial Results for the First Quarter of 2024
May 16, 2024 01:00 ET | Zealand Pharma
Company announcement - No. 26 / 2024 Zealand Pharma Announces Financial Results for the First Quarter of 2024 Strong performance in the first quarter of 2024 paving the way for important data...
zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
May 12, 2024 16:00 ET | Zealand Pharma
Company announcement – No. 25 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
zealand_logo_RGB_01.png
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results
May 09, 2024 10:00 ET | Zealand Pharma
Press Release – No. 4 / 2024 Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results Copenhagen, Denmark, May 9, 2024 – Zealand Pharma...
zealand_logo_RGB_01.png
Correction to Company announcement – No. 23 / 2024
April 19, 2024 16:20 ET | Zealand Pharma
Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology...
zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
April 19, 2024 11:05 ET | Zealand Pharma
Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
zealand_logo_RGB_01.png
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
April 19, 2024 11:00 ET | Zealand Pharma
Company announcement – No. 22 / 2024 Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024 Copenhagen,...
zealand_logo_RGB_01.png
Total number of shares and voting rights in Zealand Pharma at March 31, 2024
March 31, 2024 11:00 ET | Zealand Pharma
Company announcement – No. 21 / 2024 Total number of shares and voting rights in Zealand Pharma at March 31, 2024 Copenhagen, Denmark, March 31, 2024 – Zealand Pharma A/S (“Zealand”)...
zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
March 26, 2024 17:05 ET | Zealand Pharma
Company announcement – No. 20 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...